Robert E. Hoffman - Nov 8, 2021 Form 4 Insider Report for Kintara Therapeutics, Inc. (KTRA)

Role
President and CEO, Director
Signature
/s/ Robert Hoffman
Stock symbol
KTRA
Transactions as of
Nov 8, 2021
Transactions value $
$0
Form type
4
Date filed
11/10/2021, 03:18 PM
Previous filing
Sep 22, 2021
Next filing
Feb 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KTRA Options (Right to Buy) Award $0 +3.52M $0.00 3.52M Nov 8, 2021 Common Stock 3.52M $0.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option award was made to the reporting person pursuant to the 2017 Omnibus Equity Incentive Plan, as amended. Subject to the reporting person's continued employment, the shares subject to the option shall vest as follows: 25% of the shares subject to the option shall vest on November 8, 2022, and the remainder shall vest in equal monthly installments over the following thirty-six (36) months.

Remarks:

Exhibit 24 - Power of Attorney